Get the Stockscreener App
0.1372
3.55%
0.0047
After Hours:
.13
-0.0072
-5.25%
Zomedica Corp stock is traded at $0.1372, with a volume of 4.06M.
It is up +3.55% in the last 24 hours and up +6.44% over the past month.
Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. The company's lead drug product candidate is ZM-012, a tablet formulation of metronidazole targeting the treatment of acute diarrhea in dogs. It is also developing ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies; ZM-006, a transdermal gel formulation of methimazole targeting hyperthyroidism in cats; and ZM-011, a transdermal gel formulation of fluoxetine for the treatment of feline behavioral disorders, such as inappropriate urination. The company has a collaboration agreement with Celsee Diagnostics, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and with Seraph Biosciences, Inc. for development and commercialization of novel pathogen detection system. Zomedica Pharmaceuticals Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.
See More
Previous Close:
$0.1325
Open:
$0.1312
24h Volume:
4.06M
Relative Volume:
1.36
Market Cap:
$134.22M
Revenue:
$25.19M
Net Income/Loss:
$-34.53M
P/E Ratio:
-5.9652
EPS:
-0.023
Net Cash Flow:
$-20.62M
1W Performance:
+7.52%
1M Performance:
+6.44%
6M Performance:
-5.96%
1Y Performance:
-17.89%
1-Day Range:
$0.13
$0.1375
1-Week Range:
$0.1271
$0.1375
52-Week Range:
$0.12
$0.2285
Zomedica Corp Stock (ZOM) Company Profile
Name
Zomedica Corp
Sector
Phone
734-369-2555
Address
100 Phoenix Drive, Suite 190, Ann Arbor, MI
Zomedica Corp Stock (ZOM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-23 | Initiated | Dawson James | Buy |
Zomedica Corp Stock (ZOM) Latest News
Understanding the Risks of Investing in Zomedica Corp (ZOM) - Knox Daily
CEO HEATON LARRY C II acquired 100,000 shares of Zomedica Corp [ZOM] - Knox Daily
Market cap of Zomedica Corp [ZOM] reaches 127.59M – now what? - The DBT News
Zomedica Corp (ZOM) Stock: A Year of Market Fluctuations - The InvestChronicle
Is the Zomedica Corp (AMEX:ZOM) stock an investment opportunity? - US Post News
The time has not yet come to remove your chips from the table: Zomedica Corp (ZOM) - SETE News
ZVRA stock touches 52-week high at $8.45 amid market rally - Investing.com India
Zomedica Corp [ZOM] stock for 12,500 USD was bought by HEATON LARRY C II - Knox Daily
The Future of Zomedica Corp: Analyzing ZOM - The InvestChronicle
Should investors be concerned about Zomedica Corp (ZOM)? - US Post News
Market Momentum Report: Zomedica Corp (ZOM)’s Negative Close at 0.13 - The Dwinnex
Taking the lead: Zomedica Corp (ZOM) - SETE News
Zomedica Corp (ZOM) rating initates by Dawson James - Knox Daily
Zomedica Corp [ZOM] Records 50-Day SMA of $0.1423 - Knox Daily
Zomedica Corp (ZOM) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle
ZOM (Zomedica Corp) has impressive results - US Post News
Zomedica Completes Renovation & Upgrade of Manufacturing, Distribution, and R&D Center in Plymouth, Minnesota - AccessWire
Zomedica Completes Renovation & Upgrade of Manufacturing, Distribution, and R&D Center in Plymouth, Minnesota - StockTitan
Check out these key findings about Zomedica Corp (ZOM) - SETE News
Zomedica Corp [ZOM] Investment Guide: What You Need to Know - Knox Daily
Insider Buying: Zomedica Corp. (NYSEAMERICAN:ZOM) CEO Acquires 100,000 Shares of Stock - MarketBeat
Zomedica Corp (ZOM) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
Zomedica CEO Larry Heaton buys $12,500 in company stock - Investing.com
Zomedica CEO Larry Heaton buys $12,500 in company stock By Investing.com - Investing.com Canada
Zomedica CEO Larry Heaton buys $12,500 in company stock By Investing.com - Investing.com UK
A stock that deserves closer examination: Zomedica Corp (ZOM) - US Post News
Zomedica Secures CE Mark for TRUVIEWTM Digital Microscope & Telepathology System, Expanding Global Market Opportunities - Herald Palladium
Zomedica Secures CE Mark for TRUVIEWTM Digital Microscope & Telepathology System, Expanding Global Market Opportunities - AccessWire
Zomedica Secures CE Mark for TRUVIEWTM Digital Microscope & Telepathology System, Expanding Global Market Opportunities - StockTitan
Zomedica Pharmaceuticals Corp. (ZOM.V) (CVE:ZOM) Stock Price Down 6.6% - Defense World
Investors in cash trouble should check out Zomedica Corp (ZOM) - SETE News
The Attractiveness of Investing In Zomedica Corp (ZOM) is Growing - Knox Daily
Are Zomedica Corp (AMEX: ZOM) Analysts Predicting A Spike? - Stocks Register
Zomedica Corp [ZOM] stock for 12,900 USD was bought by POWERS JOHNNY D - Knox Daily
Zomedica's Assisi Loop(R) Product Line Designated as Fear Free(TM) Preferred Product - Herald Palladium
Zomedica's Assisi Loop(R) Product Line Designated as Fear Free(TM) Preferred Product - AccessWire
Zomedica's Assisi Loop(R) Product Line Designated as Fear Free(TM) Preferred Product - StockTitan
Zomedica Corp. (NYSEAMERICAN:ZOM) Director Buys $13,000.00 in Stock - MarketBeat
There is no doubt that Zomedica Corp (ZOM) ticks all the boxes. - SETE News
Trading Day Triumph: Zomedica Corp (ZOM) Ends at 0.13, a -2.44 Surge/Plunge - The Dwinnex
Dawson James analysts initates a Buy rating for Zomedica Corp (ZOM) - Knox Daily
ZOM’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle
Zomedica Corp [AMEX: ZOM] Sees Decrease in Stock Value - Knox Daily
Zomedica Introduces Enhanced Audio Features for the VETGuardian(R) Zero-touch Vital Signs Remote Monitoring System - AccessWire
Zomedica Introduces Enhanced Audio Features for the VETGuardian(R) Zero-touch Vital Signs Remote Monitoring System - StockTitan
Zomedica Taps Into Costa Rica With Strategic Partnership With SIRE Veterinario - MSN
More Than $9M Bet On Nerdy? Check Out These 3 Penny Stocks Executives Are Aggressively Buying - Benzinga
Is Zomedica Corp (ZOM) positioned for future growth? - SETE News
Zomedica Corp (ZOM) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Recent Insider Activity Could Benefit Zomedica Corp (ZOM) - Knoxdaily.com
Stock Surge: Zomedica Corp (ZOM) Closes at 0.14, Marking a -2.28 Increase/Decrease - The Dwinnex
Zomedica Corp Stock (ZOM) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.23%
0.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):